Search - tctmd.com

Displaying 21 - 40 of 315

Sort: Relevancy | Date

AMBULATE: Venous Closure Device Pays Off After Catheter Ablation

News Daily News

AMBULATE: Venous Closure Device Pays Off After Catheter Ablation

October 31, 2019

Comparison of Residual Shunt Rate and Complications: 6 Different PFO Closure Devices

Presentation

Comparison of Residual Shunt Rate and Complications: 6 Different PFO Closure Devices

October 30, 2019

Better Closure, More A-fib With Cardioform for PFO Closure: Retrospective Series

News Daily News

Better Closure, More A-fib With Cardioform for PFO Closure: Retrospective Series

Yael L. Maxwell

October 30, 2019

Deaths After Ablation of Atrial Fibrillation ‘Concerning’ in Real-World Analysis

News Daily News

Deaths After Ablation of Atrial Fibrillation ‘Concerning’ in Real-World Analysis

Michael O'Riordan

October 29, 2019

Multiarterial CABG ‘Underused’ in Contemporary Practice, Decreases Mortality

News Daily News

Multiarterial CABG ‘Underused’ in Contemporary Practice, Decreases Mortality

Yael L. Maxwell

October 28, 2019

Evolocumab Safe and Effective Out to 5 Years: OSLER-1

News Daily News

Evolocumab Safe and Effective Out to 5 Years: OSLER-1

Yael L. Maxwell

October 22, 2019

Sex-Based Differences in Presentation, Treatment, and Complications Among Older Adults Hospitalized for Acute MI

Presentation

Sex-Based Differences in Presentation, Treatment, and Complications Among Older Adults Hospitalized for Acute MI

October 22, 2019

Elderly Women Worse Off Than Men Before and After Acute MI

News Daily News

Elderly Women Worse Off Than Men Before and After Acute MI

Yael L. Maxwell

October 22, 2019

FDA Gives Rivaroxaban Another VTE-Related Indication

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

October 14, 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

News Conference News TCT 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

October 09, 2019

Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II

News Conference News TCT 2019

Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II

Yael L. Maxwell

October 08, 2019

Interventional Options and Future Directions for Acute PE: New AHA Statement

News Daily News

Interventional Options and Future Directions for Acute PE: New AHA Statement

October 07, 2019

In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock

News Conference News TCT 2019

In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock

October 04, 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

October 04, 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

News Conference News TCT 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

October 03, 2019

News Conference News TCT 2019

GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients?

September 30, 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

Vertebral Artery Stenting: Indications, Techniques, and Complications

Presentation TCT 2019

Vertebral Artery Stenting: Indications, Techniques, and Complications

Presenter: Charles Matouk

September 28, 2019

Alcohol Septal Ablation Complications and Management

Presentation TCT 2019

Alcohol Septal Ablation Complications and Management

Presenter: Hubert Seggewiss

September 28, 2019

Vascular Complications: How to Manage?

Presentation TCT 2019

Vascular Complications: How to Manage?

Presenter: Camille Brasselet

September 28, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.